Takamura, Y.; Kida, T.; Noma, H.; Inoue, M.; Yoshida, S.; Nagaoka, T.; Noda, K.; Yamada, Y.; Morioka, M.; Gozawa, M.;
et al. The Impact of Interval between Recurrence and Reinjection in Anti-VEGF Therapy for Diabetic Macular Edema in Pro Re Nata Regimen. J. Clin. Med. 2021, 10, 5738.
https://doi.org/10.3390/jcm10245738
AMA Style
Takamura Y, Kida T, Noma H, Inoue M, Yoshida S, Nagaoka T, Noda K, Yamada Y, Morioka M, Gozawa M,
et al. The Impact of Interval between Recurrence and Reinjection in Anti-VEGF Therapy for Diabetic Macular Edema in Pro Re Nata Regimen. Journal of Clinical Medicine. 2021; 10(24):5738.
https://doi.org/10.3390/jcm10245738
Chicago/Turabian Style
Takamura, Yoshihiro, Teruyo Kida, Hidetaka Noma, Makoto Inoue, Shigeo Yoshida, Taiji Nagaoka, Kousuke Noda, Yutaka Yamada, Masakazu Morioka, Makoto Gozawa,
and et al. 2021. "The Impact of Interval between Recurrence and Reinjection in Anti-VEGF Therapy for Diabetic Macular Edema in Pro Re Nata Regimen" Journal of Clinical Medicine 10, no. 24: 5738.
https://doi.org/10.3390/jcm10245738
APA Style
Takamura, Y., Kida, T., Noma, H., Inoue, M., Yoshida, S., Nagaoka, T., Noda, K., Yamada, Y., Morioka, M., Gozawa, M., Matsumura, T., & Inatani, M.
(2021). The Impact of Interval between Recurrence and Reinjection in Anti-VEGF Therapy for Diabetic Macular Edema in Pro Re Nata Regimen. Journal of Clinical Medicine, 10(24), 5738.
https://doi.org/10.3390/jcm10245738
